Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin.
Npj Genomic Medicine
Torres-Ayuso, Pedro P; Sahoo, Sudhakar S; Ashton, Garry G; An, Elvira E; Simms, Nicole N; Galvin, Melanie M; Leong, Hui Sun HS; Frese, Kristopher K KK; Simpson, Kathryn K; Cook, Natalie N; Hughes, Andrew A; Miller, Crispin J CJ; Marais, Richard R; Dive, Caroline C; Krebs, Matthew G MG; Brognard, John J